Approval · Notice of Compliance 11442 · 2010
SERC: Notice of Compliance 11442
Issued May 28, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11442
- Date
- May 28, 2010
- Company
- Abbott Products Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-vertigo Agent
Products in this notice
Medicinal ingredients
- BETAHISTINE HYDROCHLORIDE 16 MG per TAB
- BETAHISTINE HYDROCHLORIDE 24 MG per TAB